Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 4.77580307 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 4.77580307 |
3 | hepatocyte apoptotic process (GO:0097284) | 4.11533081 |
4 | hypotonic response (GO:0006971) | 3.61384979 |
5 | negative regulation of fibrinolysis (GO:0051918) | 3.55900057 |
6 | nuclear pore complex assembly (GO:0051292) | 3.53324685 |
7 | cysteine metabolic process (GO:0006534) | 3.48245421 |
8 | cell adhesion mediated by integrin (GO:0033627) | 3.45996450 |
9 | response to peptidoglycan (GO:0032494) | 3.45360256 |
10 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.41266194 |
11 | COPII vesicle coating (GO:0048208) | 3.38014328 |
12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.35643473 |
13 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.35137783 |
14 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.34123867 |
15 | positive regulation of nuclease activity (GO:0032075) | 3.28688835 |
16 | protein carboxylation (GO:0018214) | 3.27661932 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.27661932 |
18 | nuclear pore organization (GO:0006999) | 3.25448636 |
19 | apoptotic cell clearance (GO:0043277) | 3.24893772 |
20 | urea metabolic process (GO:0019627) | 3.22475847 |
21 | urea cycle (GO:0000050) | 3.22475847 |
22 | necroptotic process (GO:0070266) | 3.21915933 |
23 | definitive hemopoiesis (GO:0060216) | 3.18699733 |
24 | regulation of cholesterol homeostasis (GO:2000188) | 3.17895196 |
25 | mammary gland epithelial cell proliferation (GO:0033598) | 3.12201659 |
26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11887219 |
27 | L-phenylalanine catabolic process (GO:0006559) | 3.11887219 |
28 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.10580666 |
29 | sulfur amino acid catabolic process (GO:0000098) | 3.03983429 |
30 | homocysteine metabolic process (GO:0050667) | 3.03806707 |
31 | mitotic sister chromatid cohesion (GO:0007064) | 3.02980961 |
32 | regulation of nuclease activity (GO:0032069) | 2.99112169 |
33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96743856 |
34 | L-phenylalanine metabolic process (GO:0006558) | 2.96743856 |
35 | cellular response to unfolded protein (GO:0034620) | 2.94925416 |
36 | 4-hydroxyproline metabolic process (GO:0019471) | 2.94597319 |
37 | ER-nucleus signaling pathway (GO:0006984) | 2.92049595 |
38 | ER overload response (GO:0006983) | 2.91396421 |
39 | complement activation, alternative pathway (GO:0006957) | 2.88453979 |
40 | protein retention in ER lumen (GO:0006621) | 2.87828525 |
41 | regulation of keratinocyte differentiation (GO:0045616) | 2.87547448 |
42 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.86940608 |
43 | protein localization to endosome (GO:0036010) | 2.86852387 |
44 | low-density lipoprotein particle clearance (GO:0034383) | 2.86419122 |
45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.86369538 |
46 | membrane raft organization (GO:0031579) | 2.85816776 |
47 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.85450181 |
48 | regulation of fibrinolysis (GO:0051917) | 2.85110463 |
49 | cellular response to ethanol (GO:0071361) | 2.82368651 |
50 | intestinal cholesterol absorption (GO:0030299) | 2.80654480 |
51 | regulation of protein activation cascade (GO:2000257) | 2.77791227 |
52 | hippo signaling (GO:0035329) | 2.76960779 |
53 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.76388636 |
54 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.75608035 |
55 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74261115 |
56 | nitrogen cycle metabolic process (GO:0071941) | 2.71780355 |
57 | activation of Rac GTPase activity (GO:0032863) | 2.71514275 |
58 | negative regulation of fatty acid transport (GO:2000192) | 2.71155577 |
59 | hormone catabolic process (GO:0042447) | 2.70908149 |
60 | cellular response to topologically incorrect protein (GO:0035967) | 2.69496489 |
61 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.68756510 |
62 | growth hormone receptor signaling pathway (GO:0060396) | 2.68402279 |
63 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.67884721 |
64 | midgut development (GO:0007494) | 2.67747930 |
65 | cellular glucuronidation (GO:0052695) | 2.67222901 |
66 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.66810824 |
67 | regulation of complement activation (GO:0030449) | 2.66596862 |
68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66340126 |
69 | vesicle coating (GO:0006901) | 2.66303243 |
70 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.63234157 |
71 | lipoprotein metabolic process (GO:0042157) | 2.62881602 |
72 | negative regulation of DNA repair (GO:0045738) | 2.62850418 |
73 | macroautophagy (GO:0016236) | 2.62722706 |
74 | regulation of histone H3-K27 methylation (GO:0061085) | 2.62533320 |
75 | negative regulation of lipid transport (GO:0032369) | 2.61737691 |
76 | histone H3-K36 demethylation (GO:0070544) | 2.61516767 |
77 | epoxygenase P450 pathway (GO:0019373) | 2.61029290 |
78 | germ cell migration (GO:0008354) | 2.59767668 |
79 | reverse cholesterol transport (GO:0043691) | 2.59552488 |
80 | pore complex assembly (GO:0046931) | 2.59105984 |
81 | aromatic amino acid family catabolic process (GO:0009074) | 2.58303046 |
82 | TOR signaling (GO:0031929) | 2.57274516 |
83 | high-density lipoprotein particle remodeling (GO:0034375) | 2.55910649 |
84 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.55425663 |
85 | desmosome organization (GO:0002934) | 2.55014838 |
86 | intestinal absorption (GO:0050892) | 2.53649877 |
87 | pinocytosis (GO:0006907) | 2.53116795 |
88 | positive regulation of macrophage differentiation (GO:0045651) | 2.52168428 |
89 | glycine metabolic process (GO:0006544) | 2.52080865 |
90 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.51519228 |
91 | lysine metabolic process (GO:0006553) | 2.51336606 |
92 | lysine catabolic process (GO:0006554) | 2.51336606 |
93 | response to nitrosative stress (GO:0051409) | 2.51233418 |
94 | negative regulation of sterol transport (GO:0032372) | 2.50706689 |
95 | negative regulation of cholesterol transport (GO:0032375) | 2.50706689 |
96 | plasma lipoprotein particle clearance (GO:0034381) | 2.50191982 |
97 | skin morphogenesis (GO:0043589) | 2.50175316 |
98 | protein-lipid complex assembly (GO:0065005) | 2.49790766 |
99 | cellular modified amino acid catabolic process (GO:0042219) | 2.49339985 |
100 | iron ion import (GO:0097286) | 2.48719748 |
101 | regulation of necroptotic process (GO:0060544) | 2.47382619 |
102 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.47295823 |
103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47282748 |
104 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.47130639 |
105 | detection of molecule of bacterial origin (GO:0032490) | 2.46748490 |
106 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.46448862 |
107 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.45816367 |
108 | barbed-end actin filament capping (GO:0051016) | 2.45148239 |
109 | ribosome assembly (GO:0042255) | 2.44018305 |
110 | endodermal cell differentiation (GO:0035987) | 2.43939954 |
111 | response to endoplasmic reticulum stress (GO:0034976) | 2.43929046 |
112 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.43009871 |
113 | one-carbon metabolic process (GO:0006730) | 2.42833360 |
114 | bile acid biosynthetic process (GO:0006699) | 2.40514346 |
115 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.40196295 |
116 | chondrocyte development (GO:0002063) | 2.39447452 |
117 | fibrinolysis (GO:0042730) | 2.39443874 |
118 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.39289590 |
119 | hemidesmosome assembly (GO:0031581) | 2.39097448 |
120 | heterochromatin organization (GO:0070828) | 2.39025547 |
121 | serine family amino acid catabolic process (GO:0009071) | 2.38274490 |
122 | serine family amino acid metabolic process (GO:0009069) | 2.38066809 |
123 | receptor catabolic process (GO:0032801) | 2.37949981 |
124 | cellular extravasation (GO:0045123) | 2.37500990 |
125 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.37205316 |
126 | programmed necrotic cell death (GO:0097300) | 2.36936724 |
127 | regulation of plasminogen activation (GO:0010755) | 2.36738604 |
128 | regulation of translational fidelity (GO:0006450) | 2.35456455 |
129 | necrotic cell death (GO:0070265) | 2.34639434 |
130 | plasma lipoprotein particle assembly (GO:0034377) | 2.34401723 |
131 | negative regulation of necroptotic process (GO:0060546) | 2.34230312 |
132 | regulation of RNA export from nucleus (GO:0046831) | 2.34224635 |
133 | germinal center formation (GO:0002467) | 2.33871680 |
134 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.33765130 |
135 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.32710706 |
136 | embryonic process involved in female pregnancy (GO:0060136) | 2.31818769 |
137 | tyrosine metabolic process (GO:0006570) | 2.31430215 |
138 | serine family amino acid biosynthetic process (GO:0009070) | 2.31207454 |
139 | collagen fibril organization (GO:0030199) | 2.30993077 |
140 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30724996 |
141 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.28278855 |
142 | positive regulation of interferon-alpha production (GO:0032727) | 2.27272824 |
143 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.27039869 |
144 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.26931352 |
145 | intestinal epithelial cell development (GO:0060576) | 2.25746517 |
146 | response to muramyl dipeptide (GO:0032495) | 2.23945363 |
147 | cell-substrate junction assembly (GO:0007044) | 2.23054927 |
148 | membrane protein ectodomain proteolysis (GO:0006509) | 2.20681276 |
149 | cortical actin cytoskeleton organization (GO:0030866) | 2.20613312 |
150 | positive regulation of leukocyte degranulation (GO:0043302) | 2.19914131 |
151 | oligosaccharide catabolic process (GO:0009313) | 2.18600067 |
152 | early endosome to late endosome transport (GO:0045022) | 2.17827203 |
153 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.17383262 |
154 | response to laminar fluid shear stress (GO:0034616) | 2.15406353 |
155 | negative regulation of anoikis (GO:2000811) | 2.14614298 |
156 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.12771258 |
157 | establishment of endothelial barrier (GO:0061028) | 2.12037440 |
158 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.11888279 |
159 | regulation of interferon-alpha production (GO:0032647) | 2.11215566 |
160 | Golgi organization (GO:0007030) | 2.10691181 |
161 | protein export from nucleus (GO:0006611) | 2.10039204 |
162 | dosage compensation (GO:0007549) | 2.09147014 |
163 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.08871969 |
164 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.07063999 |
165 | negative regulation of interleukin-12 production (GO:0032695) | 2.06992149 |
166 | cell-substrate adherens junction assembly (GO:0007045) | 2.06572493 |
167 | focal adhesion assembly (GO:0048041) | 2.06572493 |
168 | Rap protein signal transduction (GO:0032486) | 2.05881911 |
169 | regulation of establishment of cell polarity (GO:2000114) | 2.05169219 |
170 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.04615131 |
171 | regulation of protein polyubiquitination (GO:1902914) | 2.04293306 |
172 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.03257317 |
173 | regulation of response to tumor cell (GO:0002834) | 2.03118276 |
174 | positive regulation of response to tumor cell (GO:0002836) | 2.03118276 |
175 | positive regulation of immune response to tumor cell (GO:0002839) | 2.03118276 |
176 | regulation of immune response to tumor cell (GO:0002837) | 2.03118276 |
177 | protein targeting to lysosome (GO:0006622) | 2.02783802 |
178 | establishment of protein localization to vacuole (GO:0072666) | 2.02783802 |
179 | protein targeting to vacuole (GO:0006623) | 2.02783802 |
180 | regulation of leukocyte degranulation (GO:0043300) | 2.02039024 |
181 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.01905636 |
182 | positive regulation of gamma-delta T cell activation (GO:0046645) | 1.99895244 |
183 | positive regulation of macroautophagy (GO:0016239) | 1.99612201 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.79611325 |
2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.29650821 |
3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.03789653 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.68043712 |
5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63182376 |
6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.40585178 |
7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.32172849 |
8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.23989130 |
9 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.18783894 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.15039846 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.88948611 |
12 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.81802533 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.67057511 |
14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.57132593 |
15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.40514373 |
16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.22215340 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22069022 |
18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.09113769 |
19 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.03586819 |
20 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.02460595 |
21 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.00096367 |
22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.99718839 |
23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99057801 |
24 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.96732524 |
25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.92761617 |
26 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.90493258 |
27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.90183734 |
28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.89752268 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.88061773 |
30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.84466780 |
31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.83057207 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.79357794 |
33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78105238 |
34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72452200 |
35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.66376515 |
36 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.63629306 |
37 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.62553834 |
38 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62117406 |
39 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.60500720 |
40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59986039 |
41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.59428937 |
42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57500624 |
43 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56202801 |
44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.56139791 |
45 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55174059 |
46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54854058 |
47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54217104 |
48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53863570 |
49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52568483 |
50 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.52564538 |
51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.52170451 |
52 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50443616 |
53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50131142 |
54 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.49211031 |
55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46106197 |
56 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46106197 |
57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43255373 |
58 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.42882328 |
59 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42060255 |
60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40884010 |
61 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39824768 |
62 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.38246981 |
63 | MYC_22102868_ChIP-Seq_BL_Human | 1.38193412 |
64 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38130040 |
65 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36299984 |
66 | MYB_26560356_Chip-Seq_TH1_Human | 1.35891490 |
67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35521033 |
68 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.35137270 |
69 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.34849796 |
70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33554044 |
71 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33546391 |
72 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.31140189 |
73 | MYB_26560356_Chip-Seq_TH2_Human | 1.30292212 |
74 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.29096568 |
75 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28827785 |
76 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.28500592 |
77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.27476041 |
78 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27133994 |
79 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27037277 |
80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.25868005 |
81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.23728015 |
82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23383578 |
83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21777314 |
84 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.18131298 |
85 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.16544509 |
86 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.16520939 |
87 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.16435363 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16134808 |
89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15734218 |
90 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.15591331 |
91 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.15101658 |
92 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.14422156 |
93 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12439282 |
94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10615576 |
95 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09848081 |
96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.09163436 |
97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08972735 |
98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08881423 |
99 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08802720 |
100 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08416464 |
101 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08202228 |
102 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.06726103 |
103 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.06366575 |
104 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06328807 |
105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.06297139 |
106 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06258125 |
107 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06242200 |
108 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.06084190 |
109 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05748873 |
110 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04992000 |
111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04987905 |
112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04199133 |
113 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03432780 |
114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03130047 |
115 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02460283 |
116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02234042 |
117 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01438058 |
118 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00841996 |
119 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00704248 |
120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00117087 |
121 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99853644 |
122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.99435330 |
123 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99066243 |
124 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.97825959 |
125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96660860 |
126 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96216741 |
127 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95570670 |
128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95431472 |
129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95347097 |
130 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95291648 |
131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94675924 |
132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94549343 |
133 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94061202 |
134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93212922 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93212922 |
136 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.92968974 |
137 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91924636 |
138 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.91505264 |
139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90869632 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003705_abnormal_hypodermis_morpholog | 4.12248758 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.84279188 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.83131076 |
4 | MP0005360_urolithiasis | 3.07726321 |
5 | MP0010352_gastrointestinal_tract_polyps | 2.99240280 |
6 | MP0003252_abnormal_bile_duct | 2.88528068 |
7 | MP0003300_gastrointestinal_ulcer | 2.77471727 |
8 | MP0005085_abnormal_gallbladder_physiolo | 2.68946051 |
9 | MP0005365_abnormal_bile_salt | 2.65866191 |
10 | MP0008438_abnormal_cutaneous_collagen | 2.62063879 |
11 | MP0002877_abnormal_melanocyte_morpholog | 2.59301933 |
12 | MP0008057_abnormal_DNA_replication | 2.40896506 |
13 | MP0002009_preneoplasia | 2.27740962 |
14 | MP0005451_abnormal_body_composition | 2.08781250 |
15 | MP0003566_abnormal_cell_adhesion | 2.06974983 |
16 | MP0004808_abnormal_hematopoietic_stem | 2.02224524 |
17 | MP0005076_abnormal_cell_differentiation | 1.92982487 |
18 | MP0001666_abnormal_nutrient_absorption | 1.81971795 |
19 | MP0006054_spinal_hemorrhage | 1.79224439 |
20 | MP0009053_abnormal_anal_canal | 1.78112830 |
21 | MP0002006_tumorigenesis | 1.75739980 |
22 | MP0005275_abnormal_skin_tensile | 1.75609427 |
23 | MP0001835_abnormal_antigen_presentation | 1.74300906 |
24 | MP0003763_abnormal_thymus_physiology | 1.72217437 |
25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70181527 |
26 | MP0004264_abnormal_extraembryonic_tissu | 1.68282616 |
27 | MP0002396_abnormal_hematopoietic_system | 1.67785094 |
28 | MP0010329_abnormal_lipoprotein_level | 1.60574451 |
29 | MP0009840_abnormal_foam_cell | 1.59781759 |
30 | MP0000537_abnormal_urethra_morphology | 1.55333517 |
31 | MP0003868_abnormal_feces_composition | 1.54940585 |
32 | MP0003191_abnormal_cellular_cholesterol | 1.53092681 |
33 | MP0005023_abnormal_wound_healing | 1.50541900 |
34 | MP0003828_pulmonary_edema | 1.49519453 |
35 | MP0005220_abnormal_exocrine_pancreas | 1.44019385 |
36 | MP0004272_abnormal_basement_membrane | 1.42335176 |
37 | MP0004185_abnormal_adipocyte_glucose | 1.41180427 |
38 | MP0005164_abnormal_response_to | 1.40888361 |
39 | MP0009384_cardiac_valve_regurgitation | 1.39846988 |
40 | MP0002896_abnormal_bone_mineralization | 1.39381467 |
41 | MP0010307_abnormal_tumor_latency | 1.37280082 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.36258807 |
43 | MP0005083_abnormal_biliary_tract | 1.34900997 |
44 | MP0002138_abnormal_hepatobiliary_system | 1.34286866 |
45 | MP0000465_gastrointestinal_hemorrhage | 1.33755016 |
46 | MP0003436_decreased_susceptibility_to | 1.33564575 |
47 | MP0003195_calcinosis | 1.31406692 |
48 | MP0004782_abnormal_surfactant_physiolog | 1.30179807 |
49 | MP0002060_abnormal_skin_morphology | 1.30169394 |
50 | MP0003656_abnormal_erythrocyte_physiolo | 1.28982846 |
51 | MP0003950_abnormal_plasma_membrane | 1.28935176 |
52 | MP0010678_abnormal_skin_adnexa | 1.28675177 |
53 | MP0000609_abnormal_liver_physiology | 1.26957083 |
54 | MP0005409_darkened_coat_color | 1.26325036 |
55 | MP0009697_abnormal_copulation | 1.26115756 |
56 | MP0000858_altered_metastatic_potential | 1.26040866 |
57 | MP0003091_abnormal_cell_migration | 1.25457671 |
58 | MP0003453_abnormal_keratinocyte_physiol | 1.25326870 |
59 | MP0005058_abnormal_lysosome_morphology | 1.21017224 |
60 | MP0001853_heart_inflammation | 1.20073585 |
61 | MP0004233_abnormal_muscle_weight | 1.18448883 |
62 | MP0001849_ear_inflammation | 1.18309509 |
63 | MP0004883_abnormal_blood_vessel | 1.16988014 |
64 | MP0000569_abnormal_digit_pigmentation | 1.16310967 |
65 | MP0002998_abnormal_bone_remodeling | 1.15811699 |
66 | MP0000627_abnormal_mammary_gland | 1.14977250 |
67 | MP0000685_abnormal_immune_system | 1.14429617 |
68 | MP0005464_abnormal_platelet_physiology | 1.11896798 |
69 | MP0002928_abnormal_bile_duct | 1.11573960 |
70 | MP0008007_abnormal_cellular_replicative | 1.10852749 |
71 | MP0003283_abnormal_digestive_organ | 1.10087406 |
72 | MP0001851_eye_inflammation | 1.09031320 |
73 | MP0002419_abnormal_innate_immunity | 1.08909221 |
74 | MP0001915_intracranial_hemorrhage | 1.08571352 |
75 | MP0005248_abnormal_Harderian_gland | 1.05891971 |
76 | MP0005621_abnormal_cell_physiology | 1.05842941 |
77 | MP0010155_abnormal_intestine_physiology | 1.05622211 |
78 | MP0003303_peritoneal_inflammation | 1.04451139 |
79 | MP0003183_abnormal_peptide_metabolism | 1.04421177 |
80 | MP0000733_abnormal_muscle_development | 1.03402623 |
81 | MP0008260_abnormal_autophagy | 1.03234634 |
82 | MP0004197_abnormal_fetal_growth/weight/ | 1.03223892 |
83 | MP0000383_abnormal_hair_follicle | 1.01857339 |
84 | MP0005187_abnormal_penis_morphology | 1.00279278 |
85 | MP0000598_abnormal_liver_morphology | 0.99829749 |
86 | MP0002086_abnormal_extraembryonic_tissu | 0.99683086 |
87 | MP0005623_abnormal_meninges_morphology | 0.95504419 |
88 | MP0003045_fibrosis | 0.95110308 |
89 | MP0005000_abnormal_immune_tolerance | 0.94622314 |
90 | MP0002452_abnormal_antigen_presenting | 0.93977162 |
91 | MP0002254_reproductive_system_inflammat | 0.93390617 |
92 | MP0005501_abnormal_skin_physiology | 0.92733079 |
93 | MP0005332_abnormal_amino_acid | 0.90583218 |
94 | MP0009785_altered_susceptibility_to | 0.90472893 |
95 | MP0002398_abnormal_bone_marrow | 0.89992012 |
96 | MP0003448_altered_tumor_morphology | 0.89539354 |
97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.89525164 |
98 | MP0002148_abnormal_hypersensitivity_rea | 0.88392078 |
99 | MP0009672_abnormal_birth_weight | 0.87904372 |
100 | MP0002118_abnormal_lipid_homeostasis | 0.87688117 |
101 | MP0005408_hypopigmentation | 0.87544107 |
102 | MP0009780_abnormal_chondrocyte_physiolo | 0.87287805 |
103 | MP0001800_abnormal_humoral_immune | 0.86650066 |
104 | MP0003123_paternal_imprinting | 0.86208961 |
105 | MP0008004_abnormal_stomach_pH | 0.85959410 |
106 | MP0002168_other_aberrant_phenotype | 0.85872296 |
107 | MP0001730_embryonic_growth_arrest | 0.85712073 |
108 | MP0003724_increased_susceptibility_to | 0.85550544 |
109 | MP0002092_abnormal_eye_morphology | 0.85519826 |
110 | MP0004381_abnormal_hair_follicle | 0.85442546 |
111 | MP0002405_respiratory_system_inflammati | 0.85322042 |
112 | MP0001873_stomach_inflammation | 0.85274721 |
113 | MP0005257_abnormal_intraocular_pressure | 0.84821976 |
114 | MP0002420_abnormal_adaptive_immunity | 0.84001133 |
115 | MP0005666_abnormal_adipose_tissue | 0.83911945 |
116 | MP0001819_abnormal_immune_cell | 0.83603598 |
117 | MP0003115_abnormal_respiratory_system | 0.83311825 |
118 | MP0010368_abnormal_lymphatic_system | 0.82276044 |
119 | MP0004957_abnormal_blastocyst_morpholog | 0.82110333 |
120 | MP0000427_abnormal_hair_cycle | 0.81382295 |
121 | MP0002723_abnormal_immune_serum | 0.80876961 |
122 | MP0009703_decreased_birth_body | 0.80300043 |
123 | MP0000377_abnormal_hair_follicle | 0.79876402 |
124 | MP0003279_aneurysm | 0.79493141 |
125 | MP0009643_abnormal_urine_homeostasis | 0.79481173 |
126 | MP0005025_abnormal_response_to | 0.79112547 |
127 | MP0004947_skin_inflammation | 0.78937256 |
128 | MP0001533_abnormal_skeleton_physiology | 0.78827666 |
129 | MP0001944_abnormal_pancreas_morphology | 0.78581152 |
130 | MP0002088_abnormal_embryonic_growth/wei | 0.78530656 |
131 | MP0002722_abnormal_immune_system | 0.78323080 |
132 | MP0000703_abnormal_thymus_morphology | 0.77922877 |
133 | MP0003943_abnormal_hepatobiliary_system | 0.77237224 |
134 | MP0003984_embryonic_growth_retardation | 0.77075833 |
135 | MP0002796_impaired_skin_barrier | 0.76339801 |
136 | MP0002084_abnormal_developmental_patter | 0.76306571 |
137 | MP0001845_abnormal_inflammatory_respons | 0.75116860 |
138 | MP0005384_cellular_phenotype | 0.74863159 |
139 | MP0003172_abnormal_lysosome_physiology | 0.74664431 |
140 | MP0002098_abnormal_vibrissa_morphology | 0.74422104 |
141 | MP0001672_abnormal_embryogenesis/_devel | 0.74315821 |
142 | MP0005380_embryogenesis_phenotype | 0.74315821 |
143 | MP0001545_abnormal_hematopoietic_system | 0.73908798 |
144 | MP0005397_hematopoietic_system_phenotyp | 0.73908798 |
145 | MP0000428_abnormal_craniofacial_morphol | 0.73842818 |
146 | MP0003077_abnormal_cell_cycle | 0.73812189 |
147 | MP0010094_abnormal_chromosome_stability | 0.73634737 |
148 | MP0005375_adipose_tissue_phenotype | 0.72593070 |
149 | MP0000003_abnormal_adipose_tissue | 0.72298636 |
150 | MP0000534_abnormal_ureter_morphology | 0.70988175 |
151 | MP0001243_abnormal_dermal_layer | 0.70929326 |
152 | MP0001216_abnormal_epidermal_layer | 0.70754015 |
153 | MP0000462_abnormal_digestive_system | 0.70033180 |
154 | MP0000767_abnormal_smooth_muscle | 0.69782862 |
155 | MP0003119_abnormal_digestive_system | 0.69123761 |
156 | MP0002166_altered_tumor_susceptibility | 0.68638898 |
157 | MP0005503_abnormal_tendon_morphology | 0.67519796 |
158 | MP0000350_abnormal_cell_proliferation | 0.66636522 |
159 | MP0001958_emphysema | 0.66475375 |
160 | MP0005319_abnormal_enzyme/_coenzyme | 0.66466388 |
161 | MP0003890_abnormal_embryonic-extraembry | 0.65981858 |
162 | MP0002115_abnormal_skeleton_extremities | 0.65922804 |
163 | MP0002697_abnormal_eye_size | 0.65859832 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Asymmetry of the thorax (HP:0001555) | 4.04625811 |
2 | Spinal cord lesions (HP:0100561) | 3.81582640 |
3 | Syringomyelia (HP:0003396) | 3.81582640 |
4 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.64594424 |
5 | Deep venous thrombosis (HP:0002625) | 3.53664949 |
6 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.43620664 |
7 | Cerebral aneurysm (HP:0004944) | 3.37688333 |
8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.21597813 |
9 | Intrahepatic cholestasis (HP:0001406) | 3.20057696 |
10 | Subacute progressive viral hepatitis (HP:0006572) | 3.19224692 |
11 | Absent frontal sinuses (HP:0002688) | 3.10369334 |
12 | Protrusio acetabuli (HP:0003179) | 3.07844679 |
13 | Premature rupture of membranes (HP:0001788) | 3.03458804 |
14 | Xanthomatosis (HP:0000991) | 2.96939793 |
15 | Curly hair (HP:0002212) | 2.96902183 |
16 | Complement deficiency (HP:0004431) | 2.95794125 |
17 | Aortic aneurysm (HP:0004942) | 2.85009718 |
18 | Mitral valve prolapse (HP:0001634) | 2.77675865 |
19 | Abnormality of the frontal sinuses (HP:0002687) | 2.75598399 |
20 | Spastic diplegia (HP:0001264) | 2.75088524 |
21 | Cervical subluxation (HP:0003308) | 2.69844019 |
22 | Myocardial infarction (HP:0001658) | 2.66354385 |
23 | Abnormality of oral frenula (HP:0000190) | 2.66036816 |
24 | Papillary thyroid carcinoma (HP:0002895) | 2.61782651 |
25 | Shallow orbits (HP:0000586) | 2.55383470 |
26 | Epidermoid cyst (HP:0200040) | 2.54326287 |
27 | Ankle contracture (HP:0006466) | 2.48013005 |
28 | Abnormality of the common coagulation pathway (HP:0010990) | 2.47724066 |
29 | Acute myeloid leukemia (HP:0004808) | 2.46978887 |
30 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.43581565 |
31 | Osteolytic defects of the hand bones (HP:0009699) | 2.43581565 |
32 | Termporal pattern (HP:0011008) | 2.39007820 |
33 | Insidious onset (HP:0003587) | 2.39007820 |
34 | Aortic dissection (HP:0002647) | 2.38887511 |
35 | Spondylolisthesis (HP:0003302) | 2.38676404 |
36 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38642793 |
37 | Hepatocellular carcinoma (HP:0001402) | 2.38411483 |
38 | Hypobetalipoproteinemia (HP:0003563) | 2.35057627 |
39 | Abnormality of complement system (HP:0005339) | 2.34318778 |
40 | Flat acetabular roof (HP:0003180) | 2.32812887 |
41 | Aneurysm (HP:0002617) | 2.31155795 |
42 | Thoracic kyphosis (HP:0002942) | 2.29779424 |
43 | Deep philtrum (HP:0002002) | 2.21331805 |
44 | Thick nail (HP:0001805) | 2.17283962 |
45 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.16771718 |
46 | Atrophic scars (HP:0001075) | 2.16254446 |
47 | Abnormality of glycolipid metabolism (HP:0010969) | 2.15255812 |
48 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.15255812 |
49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.15255812 |
50 | Viral hepatitis (HP:0006562) | 2.14548335 |
51 | Recurrent viral infections (HP:0004429) | 2.14008859 |
52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.13771539 |
53 | Abnormality of the thoracic spine (HP:0100711) | 2.10320355 |
54 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.09490038 |
55 | Hand muscle atrophy (HP:0009130) | 2.08101964 |
56 | Dilatation of the ascending aorta (HP:0005111) | 2.07705323 |
57 | Short nail (HP:0001799) | 2.07387054 |
58 | Rectal prolapse (HP:0002035) | 2.06446494 |
59 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06438176 |
60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.06129775 |
61 | Enlarged penis (HP:0000040) | 2.05823526 |
62 | Back pain (HP:0003418) | 2.05689600 |
63 | Mucopolysacchariduria (HP:0008155) | 2.05412227 |
64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05412227 |
65 | Hematochezia (HP:0002573) | 2.04867514 |
66 | Hypolipoproteinemia (HP:0010981) | 2.04783709 |
67 | Thin bony cortex (HP:0002753) | 2.03331245 |
68 | Lymphangioma (HP:0100764) | 2.03298106 |
69 | Thyroid carcinoma (HP:0002890) | 2.02697789 |
70 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.02364593 |
71 | Abnormality of the lumbar spine (HP:0100712) | 2.02196947 |
72 | Cutaneous melanoma (HP:0012056) | 2.02182481 |
73 | Abnormal foot bone ossification (HP:0010675) | 2.01835127 |
74 | Resting tremor (HP:0002322) | 2.01746668 |
75 | Abnormality of the columella (HP:0009929) | 2.01688356 |
76 | Peritonitis (HP:0002586) | 2.01552620 |
77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00601697 |
78 | Micronodular cirrhosis (HP:0001413) | 2.00592367 |
79 | Sparse lateral eyebrow (HP:0005338) | 2.00331338 |
80 | Aplasia cutis congenita (HP:0001057) | 2.00020324 |
81 | Hypoalphalipoproteinemia (HP:0003233) | 1.99888652 |
82 | Mitral stenosis (HP:0001718) | 1.99797553 |
83 | Systemic lupus erythematosus (HP:0002725) | 1.98128806 |
84 | Capillary hemangiomas (HP:0005306) | 1.96919895 |
85 | Ulnar bowing (HP:0003031) | 1.96102464 |
86 | Autoimmune hemolytic anemia (HP:0001890) | 1.96029205 |
87 | Bladder neoplasm (HP:0009725) | 1.95914769 |
88 | Bladder carcinoma (HP:0002862) | 1.95914769 |
89 | Arterial tortuosity (HP:0005116) | 1.95845199 |
90 | Esophageal varix (HP:0002040) | 1.95410961 |
91 | Abnormal cartilage morphology (HP:0002763) | 1.95245653 |
92 | Tetraparesis (HP:0002273) | 1.95115853 |
93 | Genu recurvatum (HP:0002816) | 1.95019766 |
94 | Increased mean platelet volume (HP:0011877) | 1.93291235 |
95 | Macroorchidism (HP:0000053) | 1.92550225 |
96 | Focal segmental glomerulosclerosis (HP:0000097) | 1.91607908 |
97 | Eczematoid dermatitis (HP:0000976) | 1.91595649 |
98 | T lymphocytopenia (HP:0005403) | 1.90754648 |
99 | Relative macrocephaly (HP:0004482) | 1.88676311 |
100 | Upper limb amyotrophy (HP:0009129) | 1.88541401 |
101 | Distal upper limb amyotrophy (HP:0007149) | 1.88541401 |
102 | Deviation of the thumb (HP:0009603) | 1.88441684 |
103 | Vascular tortuosity (HP:0004948) | 1.88009834 |
104 | Skin nodule (HP:0200036) | 1.85664720 |
105 | Right ventricular cardiomyopathy (HP:0011663) | 1.84359005 |
106 | Glomerulonephritis (HP:0000099) | 1.83786853 |
107 | Epiphyseal dysplasia (HP:0002656) | 1.81922053 |
108 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.81824718 |
109 | Hyperglycemia (HP:0003074) | 1.80992680 |
110 | Abnormality of macrophages (HP:0004311) | 1.80929153 |
111 | Protuberant abdomen (HP:0001538) | 1.80831389 |
112 | Germ cell neoplasia (HP:0100728) | 1.80425662 |
113 | Fat malabsorption (HP:0002630) | 1.80367659 |
114 | Colitis (HP:0002583) | 1.80327272 |
115 | Hypoglycemic coma (HP:0001325) | 1.79821042 |
116 | Retinal atrophy (HP:0001105) | 1.79217905 |
117 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79080128 |
118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79024565 |
119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79024565 |
120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79024565 |
121 | Abnormality of the Achilles tendon (HP:0005109) | 1.78819806 |
122 | Exostoses (HP:0100777) | 1.78014503 |
123 | Turricephaly (HP:0000262) | 1.77916829 |
124 | Abnormality of proline metabolism (HP:0010907) | 1.76416654 |
125 | Hydroxyprolinuria (HP:0003080) | 1.76416654 |
126 | Thickened calvaria (HP:0002684) | 1.76388636 |
127 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.75618732 |
128 | Tibial bowing (HP:0002982) | 1.74986196 |
129 | Ankyloglossia (HP:0010296) | 1.74400332 |
130 | Broad face (HP:0000283) | 1.74175741 |
131 | Metaphyseal cupping (HP:0003021) | 1.73767339 |
132 | Striae distensae (HP:0001065) | 1.73307357 |
133 | Interstitial pulmonary disease (HP:0006530) | 1.72788945 |
134 | Glomerulosclerosis (HP:0000096) | 1.72762158 |
135 | Buphthalmos (HP:0000557) | 1.72242591 |
136 | Disproportionate tall stature (HP:0001519) | 1.70727233 |
137 | Radial bowing (HP:0002986) | 1.70703238 |
138 | Facial hemangioma (HP:0000329) | 1.69911384 |
139 | Thoracolumbar scoliosis (HP:0002944) | 1.69420808 |
140 | Hypoglycemic seizures (HP:0002173) | 1.69001855 |
141 | Blue sclerae (HP:0000592) | 1.68776697 |
142 | Fatigue (HP:0012378) | 1.68737667 |
143 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.68686104 |
144 | Microglossia (HP:0000171) | 1.68229241 |
145 | Abnormality of T cell number (HP:0011839) | 1.67924725 |
146 | Recurrent abscess formation (HP:0002722) | 1.67666755 |
147 | Craniofacial hyperostosis (HP:0004493) | 1.67665913 |
148 | Biliary tract neoplasm (HP:0100574) | 1.67228541 |
149 | Increased density of long bones (HP:0006392) | 1.67201509 |
150 | Abnormality of nail color (HP:0100643) | 1.66721927 |
151 | Abnormality of the gastric mucosa (HP:0004295) | 1.66611713 |
152 | Cupped ribs (HP:0000887) | 1.66535234 |
153 | Camptodactyly of toe (HP:0001836) | 1.66082936 |
154 | Abdominal distention (HP:0003270) | 1.65627396 |
155 | Low anterior hairline (HP:0000294) | 1.64949519 |
156 | Dysostosis multiplex (HP:0000943) | 1.64682299 |
157 | Hallux valgus (HP:0001822) | 1.63988813 |
158 | Lower limb hyperreflexia (HP:0002395) | 1.63461518 |
159 | Renal cell carcinoma (HP:0005584) | 1.63366543 |
160 | Menstrual irregularities (HP:0000858) | 1.63191080 |
161 | Recurrent bacterial skin infections (HP:0005406) | 1.63041889 |
162 | Milia (HP:0001056) | 1.62921293 |
163 | Inflammation of the large intestine (HP:0002037) | 1.62859545 |
164 | Wormian bones (HP:0002645) | 1.62796123 |
165 | Periodontitis (HP:0000704) | 1.62477595 |
166 | Abnormality of the acetabulum (HP:0003170) | 1.62451544 |
167 | Gastrointestinal carcinoma (HP:0002672) | 1.62384916 |
168 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.62384916 |
169 | Coarse hair (HP:0002208) | 1.62317351 |
170 | Increased CSF protein (HP:0002922) | 1.62039220 |
171 | Reduced antithrombin III activity (HP:0001976) | 1.61557401 |
172 | Alopecia of scalp (HP:0002293) | 1.60330355 |
173 | Loss of speech (HP:0002371) | 1.58942839 |
174 | Prominent nose (HP:0000448) | 1.58925137 |
175 | Osteomyelitis (HP:0002754) | 1.58350710 |
176 | Leiomyosarcoma (HP:0100243) | 1.57605717 |
177 | Uterine leiomyosarcoma (HP:0002891) | 1.57605717 |
178 | Heterotopia (HP:0002282) | 1.57497297 |
179 | Arterial thrombosis (HP:0004420) | 1.56656616 |
180 | Gastrointestinal inflammation (HP:0004386) | 1.56606759 |
181 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.55342827 |
182 | B lymphocytopenia (HP:0010976) | 1.55285527 |
183 | Cellulitis (HP:0100658) | 1.55219816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PKN2 | 3.72793809 |
2 | LATS1 | 3.69606969 |
3 | TRIB3 | 3.40419690 |
4 | FRK | 2.94523293 |
5 | EIF2AK3 | 2.87179444 |
6 | IRAK3 | 2.71367403 |
7 | SCYL2 | 2.63760974 |
8 | PTK6 | 2.52860884 |
9 | ERN1 | 2.23622966 |
10 | EPHA2 | 2.20517679 |
11 | STK3 | 2.16346402 |
12 | PDGFRA | 2.08608391 |
13 | BMPR2 | 2.01536362 |
14 | EEF2K | 1.93940672 |
15 | PRPF4B | 1.90733101 |
16 | RIPK1 | 1.89447177 |
17 | SIK3 | 1.87331196 |
18 | CDK12 | 1.82039997 |
19 | DDR2 | 1.72684503 |
20 | MARK3 | 1.72291837 |
21 | CDK6 | 1.69588435 |
22 | MAP3K2 | 1.65932595 |
23 | MET | 1.62090368 |
24 | SIK1 | 1.61746448 |
25 | FLT3 | 1.61425302 |
26 | BRD4 | 1.61309492 |
27 | TGFBR2 | 1.59897301 |
28 | MAP3K10 | 1.58730832 |
29 | TTN | 1.56869484 |
30 | IRAK4 | 1.54983528 |
31 | MAP3K13 | 1.46944131 |
32 | CAMK1D | 1.44659919 |
33 | PTK2 | 1.43198884 |
34 | MST1R | 1.42178561 |
35 | PAK4 | 1.41070649 |
36 | FER | 1.39400108 |
37 | SMG1 | 1.36081982 |
38 | PAK2 | 1.33986150 |
39 | IRAK2 | 1.30051885 |
40 | LRRK2 | 1.29807090 |
41 | MTOR | 1.23082303 |
42 | STK10 | 1.22515950 |
43 | RET | 1.22451147 |
44 | RPS6KA4 | 1.21608411 |
45 | MAP3K3 | 1.20634099 |
46 | TAOK3 | 1.18625139 |
47 | FGFR4 | 1.17643851 |
48 | ZAP70 | 1.15830038 |
49 | PASK | 1.15609771 |
50 | MAP2K3 | 1.12579599 |
51 | NEK9 | 1.11381122 |
52 | PDGFRB | 1.11264497 |
53 | CAMK1G | 1.09304384 |
54 | EIF2AK1 | 1.07841905 |
55 | EPHA3 | 1.05752507 |
56 | ERBB4 | 1.05183057 |
57 | BMX | 1.04649548 |
58 | NUAK1 | 1.04173010 |
59 | ALK | 1.03436912 |
60 | FGFR1 | 1.03160638 |
61 | MST4 | 1.02571530 |
62 | MAP3K8 | 0.97228790 |
63 | MELK | 0.96351922 |
64 | YES1 | 0.95801583 |
65 | RPS6KB2 | 0.95263539 |
66 | BRSK2 | 0.94175413 |
67 | EPHB1 | 0.92892865 |
68 | NEK2 | 0.92774875 |
69 | NME2 | 0.91728441 |
70 | FGFR2 | 0.89768430 |
71 | ERBB3 | 0.89402723 |
72 | LATS2 | 0.88996653 |
73 | KSR1 | 0.86754555 |
74 | NEK6 | 0.85725249 |
75 | RPS6KB1 | 0.81628779 |
76 | SGK3 | 0.81159497 |
77 | IRAK1 | 0.81118809 |
78 | FGFR3 | 0.80486797 |
79 | JAK1 | 0.79831712 |
80 | KSR2 | 0.78225152 |
81 | MATK | 0.76972406 |
82 | CSK | 0.73173676 |
83 | STK39 | 0.72907601 |
84 | RIPK4 | 0.70747983 |
85 | PBK | 0.70041654 |
86 | ICK | 0.68053979 |
87 | JAK3 | 0.66601199 |
88 | CDC7 | 0.66547827 |
89 | MAP3K6 | 0.65824601 |
90 | CDK4 | 0.65652322 |
91 | AKT3 | 0.62839550 |
92 | CSNK1A1L | 0.62422209 |
93 | GSK3A | 0.61249041 |
94 | JAK2 | 0.60484886 |
95 | TAF1 | 0.60318136 |
96 | MAP3K12 | 0.59110223 |
97 | MOS | 0.58806198 |
98 | CSF1R | 0.58586745 |
99 | TTK | 0.55305727 |
100 | CDK9 | 0.53357159 |
101 | EGFR | 0.52635905 |
102 | PDPK1 | 0.52332587 |
103 | STK38 | 0.52277952 |
104 | TSSK6 | 0.51439351 |
105 | CDK7 | 0.51363847 |
106 | BCKDK | 0.50241731 |
107 | FGR | 0.50199478 |
108 | PAK3 | 0.50153811 |
109 | STK38L | 0.50107437 |
110 | TGFBR1 | 0.47694284 |
111 | ERBB2 | 0.47547399 |
112 | EIF2AK2 | 0.47382929 |
113 | BTK | 0.46703257 |
114 | MAP2K2 | 0.46030954 |
115 | PIK3CA | 0.45349240 |
116 | MAPK15 | 0.45194985 |
117 | NLK | 0.44780736 |
118 | HCK | 0.44647724 |
119 | CLK1 | 0.44557298 |
120 | PRKG2 | 0.44317751 |
121 | MAP2K1 | 0.44075482 |
122 | NEK1 | 0.43238105 |
123 | INSRR | 0.43170229 |
124 | INSR | 0.41861331 |
125 | DYRK1B | 0.41598335 |
126 | MAP3K5 | 0.39665261 |
127 | NTRK1 | 0.38311262 |
128 | HIPK2 | 0.37831897 |
129 | IGF1R | 0.37205273 |
130 | PIK3CG | 0.37167158 |
131 | TBK1 | 0.36999210 |
132 | CHUK | 0.36897298 |
133 | EPHB2 | 0.36563490 |
134 | ABL1 | 0.35272205 |
135 | MAP3K14 | 0.34710006 |
136 | MAP3K1 | 0.33605465 |
137 | CAMKK1 | 0.32806808 |
138 | MAP3K7 | 0.31772695 |
139 | TYK2 | 0.31153457 |
140 | STK24 | 0.30817412 |
141 | MAP3K9 | 0.30528508 |
142 | PIM1 | 0.30260916 |
143 | PRKD3 | 0.29645251 |
144 | TRPM7 | 0.29378984 |
145 | PLK3 | 0.29241878 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88041636 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71268665 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.43455734 |
4 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.17387672 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05936913 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.01120490 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.86307065 |
8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84879274 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77508474 |
10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.70843686 |
11 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.66078237 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.57309010 |
13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56998447 |
14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52503151 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51569344 |
16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48253432 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46572914 |
18 | Hepatitis B_Homo sapiens_hsa05161 | 1.46238170 |
19 | Measles_Homo sapiens_hsa05162 | 1.41557234 |
20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41309595 |
21 | Lysine degradation_Homo sapiens_hsa00310 | 1.36408802 |
22 | Apoptosis_Homo sapiens_hsa04210 | 1.34034767 |
23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33749231 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.32059369 |
25 | Adherens junction_Homo sapiens_hsa04520 | 1.31557592 |
26 | Hepatitis C_Homo sapiens_hsa05160 | 1.31412820 |
27 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31342348 |
28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31157856 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30739690 |
30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26926915 |
31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.26412018 |
32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26374005 |
33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25397668 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24086840 |
35 | Influenza A_Homo sapiens_hsa05164 | 1.24029408 |
36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23387014 |
37 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21670458 |
38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20770256 |
39 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.20628481 |
40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20573058 |
41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20561925 |
42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.20470496 |
43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19894888 |
44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16260245 |
45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13565796 |
46 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.12963033 |
47 | Focal adhesion_Homo sapiens_hsa04510 | 1.11713488 |
48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.11544798 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.10690993 |
50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10672035 |
51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10667474 |
52 | Tuberculosis_Homo sapiens_hsa05152 | 1.10531463 |
53 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10334998 |
54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10093328 |
55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.09665753 |
56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09404438 |
57 | Bladder cancer_Homo sapiens_hsa05219 | 1.07968405 |
58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06830168 |
59 | Shigellosis_Homo sapiens_hsa05131 | 1.05464056 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.04707865 |
61 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03453555 |
62 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.02959609 |
63 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01966975 |
64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00256182 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99904610 |
66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.97320727 |
67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.97224876 |
68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.95984281 |
69 | Amoebiasis_Homo sapiens_hsa05146 | 0.95119269 |
70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.94734270 |
71 | Insulin resistance_Homo sapiens_hsa04931 | 0.93256425 |
72 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92824990 |
73 | Prostate cancer_Homo sapiens_hsa05215 | 0.91594136 |
74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91585973 |
75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91214817 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.90260974 |
77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.90076102 |
78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87199130 |
79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86750934 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86262595 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85122600 |
82 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83312578 |
83 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82020686 |
84 | Lysosome_Homo sapiens_hsa04142 | 0.81950247 |
85 | Salmonella infection_Homo sapiens_hsa05132 | 0.81842036 |
86 | Melanoma_Homo sapiens_hsa05218 | 0.80726913 |
87 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80234663 |
88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.79226956 |
89 | Malaria_Homo sapiens_hsa05144 | 0.78645893 |
90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.78633305 |
91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.77845815 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77637017 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.75934240 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75386365 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74771373 |
96 | Prion diseases_Homo sapiens_hsa05020 | 0.74648645 |
97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.70591664 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69146647 |
99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69066310 |
100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68926670 |
101 | Pertussis_Homo sapiens_hsa05133 | 0.68675313 |
102 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68596923 |
103 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67483070 |
104 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67310109 |
105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66007253 |
106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64785572 |
107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.63057744 |
108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62496584 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62414551 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62284264 |
111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61669772 |
112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60913774 |
113 | Glioma_Homo sapiens_hsa05214 | 0.60749647 |
114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60673285 |
115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.60311334 |
116 | Phagosome_Homo sapiens_hsa04145 | 0.60297787 |
117 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.60192401 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59847203 |
119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59820083 |
120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59169192 |
121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58746511 |
122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58585642 |
123 | Endocytosis_Homo sapiens_hsa04144 | 0.58583342 |
124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58388589 |
125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58102187 |
126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57743834 |
127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56543862 |
128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55690710 |
129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.55316356 |
130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54603834 |
131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.54483484 |
132 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54240065 |
133 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53911809 |
134 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53689917 |
135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.53030727 |
136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52504987 |
137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50977407 |
138 | Peroxisome_Homo sapiens_hsa04146 | 0.50864390 |
139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50692687 |
140 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50433017 |
141 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49608554 |
142 | Legionellosis_Homo sapiens_hsa05134 | 0.48888616 |
143 | Gap junction_Homo sapiens_hsa04540 | 0.48668705 |
144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47733512 |
145 | Platelet activation_Homo sapiens_hsa04611 | 0.46708357 |
146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46216363 |
147 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45603819 |
148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45161042 |
149 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44802468 |
150 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44339059 |
151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43968922 |
152 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43858693 |
153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43444137 |
154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43167842 |
155 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.43000555 |
156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.42119502 |
157 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41995354 |
158 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41572112 |